Antitumor Activity Of Ascorbic Acid In Combination...[in Vivo. 1988 May-aug] - Pubmed Result

A service of the U.S. National Library of Medicine and the National Institutes of Health

All Databases

Search

Nucleotide

PubMed

Limits Clear Display All: 1

PubMed

Preview/Index

Protein

Genome

Structure

OMIM

My NCBI [Sign In] [Register] PMC

Journals

Clipboard

AbstractPlus

Advanced Search

Go

for History

Books

Details Show

20

Sort By

Send to

Review: 0 Links

1: In Vivo. 1988 May-Aug;2(3-4):247-52.

Antitumor activity of ascorbic acid in combination with antitumor agents against Lewis lung carcinoma. Nakano K, Fujimoto S, Tokita H.

Related Articles Antitumor activity of calcium in combination with antitumor agents against Lewis lung carcinoma. [I nVivo. 1989] [Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 lung [Gmice an Tobearing Kag akuLewis Ry oho. 1986]

Shizuoka Sena Hospital, Japan.

Antitumor activity of ascorbic acid in combination with antitumor agents (mitomycin C and 5-fluorouracil) was examined against subcutaneously implanted Lewis lung carcinoma-bearing C57BL/6 mice by feeding them an ascorbic acid-deficient diet. The mice were divided into four groups: group 1 received intraperitoneally mitomycin C (2 mg/kg) and 5-fluorouracil (50 mg/kg) once a week for four weeks beginning from the day after implantation of tumors, as well as ascorbic acid (1000 mg/kg) twice a week for the same four weeks; group 2 received only mitomycin C and 5-fluorouracil; group 3 received only ascorbic acid; group 4 received a vehicle (physiological saline). Tumor growth of group 1 compared with the other three groups, and that of group 2 compared with groups 3 and 4, was significantly inhibited by day 13 post implantation. Histological examinations of tumor tissues at 10 days after implantation of tumors already showed degenerative changes which indicated these antitumor effects.

Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted [ClinCancer Res. 1997] Antitumor activity of cryptophycins: effect of infusion time and combination studies. [Cancer Chemoth er Pha rmacol. 2000] Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. [Cancer Res. 1994] » See All...

Patient Drug Information Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body.

PMID: 2979840 [PubMed - indexed for MEDLINE]

Fluorouracil (Adrucil® ) Your doctor has ordered the drug fluorouracil to help treat your illness. The drug is given by injection into a vein. Mitomycin (Mutamycin® ) Your doctor has ordered the drug mitomycin to help treat your illness. The drug is given by injection into a vein. Source: AHFS Consumer Medication Information

Recent Activity Turn Off

Clear

Antitumor activity of ascorbic acid in combination with antitumor agents against Lewis lun... Effect of ascorbic acid on the intragastric environment in patients at increased risk of d... Ultrastructure and cell surface studies of cancer cells following vitamin C administration... Potential protective effect of vitamin C on carcinogenesis caused by nitrosamine in drinki... Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid...

Display

AbstractPlus

Show

20

Sort By

Send to

Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer